5. Progressive supranuclear palsy Clinical trials / Disease details

Clinical trials : 95 / Drugs : 119 - (DrugBank : 40) / Drug target genes : 65 - Drug target pathways : 108

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2013-003740-23-ES (EUCTR)	04/02/2015	05/12/2013	Evaluation of masitinib in the treatment of Progressive Supranuclear Palsy	A prospective, multicentre, randomised, double-blind, placebo-controlled, parallel groups, phase 2b/ ...	Progressive Supranuclear Palsy MedDRA version: 14.1;Level: PT;Classification code 10036813;Term: Pro ...	Product Name: masitinib 100mg Product Code: AB1010 INN or Proposed INN: Masitinib mesylate Other descript ...	AB Science	NULL	Not Recruiting			Female: yes Male: yes	90	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	Spain

First Previous1Next Last